CARB-X
Overview
CARB-X is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world . CARB-X supports innovative therapeutics, preventatives and rapid diagnostics . It integrates solutions for the prevention, diagnosis, and treatment of life-threatening bacterial infections .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Visby Medical | Jan 2025 | Grant | Lead |
| Peptilogics | Jan 2025 | Grant | Co-investor |
| Bioversys | Jun 2021 | Grant | Co-investor |
| Oxford Drug Design | Jun 2019 | Grant | Co-investor |
| Fuse Diagnostics | Jun 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CARB-X based?
CARB-X is headquartered in Boston, Massachusetts, United States.
When was CARB-X founded?
CARB-X was founded in 2016.
How many portfolio companies does CARB-X have?
CARB-X has 61 portfolio companies in Caplight's dataset.
What are some companies in CARB-X's portfolio?
Portfolio companies visible on Caplight include Visby Medical, Peptilogics, Bioversys, Oxford Drug Design, Fuse Diagnostics.
What was CARB-X's most recent investment shown here?
CARB-X's most recent investment in this portfolio sample was in Visby Medical in 2025.
What sectors does CARB-X focus on?
CARB-X focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does CARB-X focus on?
CARB-X typically invests at the MultiStage stage.
What is CARB-X's AUM?
CARB-X's assets under management are estimated between $250.0M and $500.0M.